These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31207556)

  • 1. Engineering of binding functions into proteins.
    Gebauer M; Skerra A
    Curr Opin Biotechnol; 2019 Dec; 60():230-241. PubMed ID: 31207556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Protein Scaffolds as Next-Generation Therapeutics.
    Gebauer M; Skerra A
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():391-415. PubMed ID: 31914898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the development of novel protein scaffolds based therapeutics.
    Azhar A; Ahmad E; Zia Q; Rauf MA; Owais M; Ashraf GM
    Int J Biol Macromol; 2017 Sep; 102():630-641. PubMed ID: 28412342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.
    Wurch T; Pierré A; Depil S
    Trends Biotechnol; 2012 Nov; 30(11):575-82. PubMed ID: 22944617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding proteins from alternative scaffolds.
    Nygren PA; Skerra A
    J Immunol Methods; 2004 Jul; 290(1-2):3-28. PubMed ID: 15261569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein scaffolds: antibody alternatives for cancer diagnosis and therapy.
    Luo R; Liu H; Cheng Z
    RSC Chem Biol; 2022 Jul; 3(7):830-847. PubMed ID: 35866165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered protein scaffolds for molecular recognition.
    Skerra A
    J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on discovery research and clinical validation.
    Wurch T; Lowe P; Caussanel V; Bes C; Beck A; Corvaia N
    Curr Pharm Biotechnol; 2008 Dec; 9(6):502-9. PubMed ID: 19075688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Library of binding protein scaffolds (LibBP): a computational platform for selection of binding protein scaffolds.
    Hong S; Kim D
    Bioinformatics; 2016 Jun; 32(11):1709-15. PubMed ID: 26826717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-engineered biomaterials: highly tunable tissue engineering scaffolds.
    Sengupta D; Heilshorn SC
    Tissue Eng Part B Rev; 2010 Jun; 16(3):285-93. PubMed ID: 20141386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering novel bioactive mini-proteins from small size natural and de novo designed scaffolds.
    Martin L; Vita C
    Curr Protein Pept Sci; 2000 Dec; 1(4):403-30. PubMed ID: 12369907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacing antibodies: engineering new binding proteins.
    Banta S; Dooley K; Shur O
    Annu Rev Biomed Eng; 2013; 15():93-113. PubMed ID: 23642248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant protein scaffolds for tissue engineering.
    Werkmeister JA; Ramshaw JA
    Biomed Mater; 2012 Feb; 7(1):012002. PubMed ID: 22262725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics.
    Boersma YL
    Methods Mol Biol; 2018; 1798():307-327. PubMed ID: 29868969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Antibodies in Small-Molecule Drug Discovery.
    Marsden CJ; Eckersley S; Hebditch M; Kvist AJ; Milner R; Mitchell D; Warwicker J; Marley AE
    J Biomol Screen; 2014 Jul; 19(6):829-38. PubMed ID: 24695620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered antibody variable and constant domains as therapeutic candidates.
    Gong R; Xiao G
    Pharm Pat Anal; 2013 Sep; 2(5):637-46. PubMed ID: 24237171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotransporter-Mediated Display of a Naïve Affibody Library on the Outer Membrane of Escherichia coli.
    Andersson KG; Persson J; Ståhl S; Löfblom J
    Biotechnol J; 2019 Apr; 14(4):e1800359. PubMed ID: 30179307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.